Compare DGAC & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DGAC | NAGE |
|---|---|---|
| Founded | N/A | 1999 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 224.5M | 261.2M |
| IPO Year | 2026 | 2010 |
| Metric | DGAC | NAGE |
|---|---|---|
| Price | $9.96 | $3.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 211.3K | ★ 709.8K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.82 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $129,423,000.00 |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $33.89 |
| Revenue Growth | N/A | ★ 29.95 |
| 52 Week Low | $9.85 | $2.87 |
| 52 Week High | $10.00 | $10.52 |
| Indicator | DGAC | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 69.03 | 40.65 |
| Support Level | $9.85 | $2.87 |
| Resistance Level | $10.00 | $3.61 |
| Average True Range (ATR) | 0.02 | 0.14 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 100.00 | 20.53 |
Disciplined Growth Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.